# Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Study · id `cardio:ct-nct06082063` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06082063](<https://clinicaltrials.gov/study/NCT06082063>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06082063

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2000 participants.

## Technical summary

Registry record NCT06082063. Randomized; no masking; primary purpose treatment. Start 2024-07-01 (actual); primary completion 2029-07-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 2000 participants (planned count; ClinicalTrials.gov record NCT06082063, source copy `cardio:ctgov-nct06082063-2025-01-10`, retrieved 2026-10-26)
- Started: 2024-07-01 (actual) (ClinicalTrials.gov record NCT06082063, source copy `cardio:ctgov-nct06082063-2025-01-10`, retrieved 2026-10-26)
- Primary completion: 2029-07-01 (anticipated) (ClinicalTrials.gov record NCT06082063, source copy `cardio:ctgov-nct06082063-2025-01-10`, retrieved 2026-10-26)
- Completion: 2029-07-01 (anticipated) (ClinicalTrials.gov record NCT06082063, source copy `cardio:ctgov-nct06082063-2025-01-10`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT06082063, source copy `cardio:ctgov-nct06082063-2025-01-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06082063-2025-01-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes
- Acronym: Steno1
- Condition: Cardiovascular Diseases
- Condition: Heart Failure
- Condition: Type 1 Diabetes
- Condition: Kidney Failure
- Intervention (Drug): Aspirin tablet
- Intervention (Drug): Semaglutide
- Intervention (Drug): Sotagliflozin
- Intervention (Drug): Finerenone
- Lead sponsor: Steno Diabetes Center Copenhagen
- Lead sponsor class: OTHER
- Collaborator: Aarhus University Hospital
- Collaborator class: OTHER
- Collaborator: Steno Diabetes Center Nordjylland
- Collaborator class: OTHER
- Collaborator: Steno Diabetes Center Odense
- Collaborator class: OTHER
- Collaborator: Slagelse Hospital
- Collaborator class: OTHER
- Collaborator: Nykøbing Falster County Hospital
- Collaborator class: OTHER
- Collaborator: Zealand University Hospital
- Collaborator class: OTHER
- Collaborator: Hillerod Hospital, Denmark
- Collaborator class: OTHER
- Collaborator: Copenhagen University Hospital, Rigshospitalet
- Collaborator class: OTHER
- Collaborator: Hvidovre University Hospital
- Collaborator class: OTHER
- Collaborator: Regionshospitalet Viborg, Skive
- Collaborator class: OTHER
- Collaborator: Randers Regional Hospital
- Collaborator class: OTHER
- Collaborator: Herning Hospital
- Collaborator class: OTHER
- Collaborator: Esbjerg Hospital - University Hospital of Southern Denmark
- Collaborator class: OTHER
- Collaborator: Regionshospitalet Silkeborg
- Collaborator class: OTHER
- Collaborator: Bispebjerg Hospital
- Collaborator class: OTHER
- Collaborator: Regionshospitalet Horsens
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Diabetes mellitus (`core:diabetes-mellitus`)
- Registry condition terms include this condition: Type 1 diabetes (`core:type-1-diabetes`)
- Registry intervention name matches this record: Semaglutide (`cardio:semaglutide`)
- Registry intervention name matches this record: Finerenone (`cardio:finerenone`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 13 registry organizations

## Provenance

Content hash: 408ec5809f0553bc1df25c2502433f919138dfe4345b317be8304ea02c7533e6
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
